Diana Fandino

Statistics

Publications

Citations

H-Index

Active since

2021

Affiliations

Washington University in St. Louis(Current)

Baylor College of Medicine

Baylor Genetics

Children's Cancer Center

Diana Fandino is an author at Washington University in St. Louis specializing in estrogen receptors, cancer cell signaling, and signal transduction in cancer.

ORCID

Publications per year

2021–2024

Publications

Transcriptional Reprogramming Differentiates Active from Inactive ESR1 Fusions in Endocrine Therapy-Refractory Metastatic Breast Cancer

Xuxu Gou, Meenakshi Anurag, Jonathan T. Lei et al. · Cancer Research · 2021 · 24 citations · Full text

Medicine, Molecular Biology, Oncology +17

PKMYT1 Is a Marker of Treatment Response and a Therapeutic Target for CDK4/6 Inhibitor-Resistance in ER+ Breast Cancer

Anran Chen, Beom-Jun Kim, Aparna Mitra et al. · Molecular Cancer Therapeutics · 2024 · 21 citations · Full text

Medicine, Oncology, Pharmacology +17

Kinome Reprogramming Is a Targetable Vulnerability in ESR1 Fusion-Driven Breast Cancer

Xuxu Gou, Beom-Jun Kim, Meenakshi Anurag et al. · Cancer Research · 2023 · 12 citations · Full text

Medicine, Molecular Biology, Oncology +15

1–3 of 3